Fact Check: Pfas are found in the blood of nearly every person on Earth.

Fact Check: Pfas are found in the blood of nearly every person on Earth.

Published July 1, 2025
±
VERDICT
Partially True

# Fact Check: "PFAS are found in the blood of nearly every person on Earth." ## What We Know Per- and polyfluoroalkyl substances (PFAS) are a group o...

Fact Check: "PFAS are found in the blood of nearly every person on Earth."

What We Know

Per- and polyfluoroalkyl substances (PFAS) are a group of synthetic chemicals that have been widely used in various industries and consumer products for decades. According to the National Institute of Environmental Health Sciences (NIEHS), human exposure to PFAS is widespread, with studies indicating that PFAS have been detected in the blood of approximately 97% of Americans (NIEHS). The Agency for Toxic Substances and Disease Registry (ATSDR) corroborates this, stating that nearly all individuals in the U.S. have PFAS in their blood, based on data collected from the National Health and Nutrition Examination Survey (NHANES) since 1999 (ATSDR).

The presence of PFAS in human blood is attributed to various exposure routes, including contaminated drinking water, food, and consumer products. These chemicals are persistent in the environment and can accumulate in the human body over time (NIEHS). While the levels of some specific PFAS, such as PFOS and PFOA, have decreased in recent years due to regulatory actions, new PFAS compounds continue to emerge, complicating the assessment of overall exposure (ATSDR).

Analysis

The claim that PFAS are found in the blood of nearly every person on Earth is supported by substantial evidence, particularly in the context of the U.S. population. The NIEHS and ATSDR reports provide strong data indicating that a significant majority of Americans have detectable levels of PFAS in their blood. However, the assertion lacks specificity regarding global prevalence. While studies indicate widespread exposure in the U.S., data on PFAS presence in blood samples from other countries may not be as comprehensive or readily available.

Moreover, the term "nearly every person on Earth" implies a universal presence, which may not accurately reflect the variability in exposure levels based on geography, occupation, and local environmental conditions (NIEHS). For instance, populations in areas with known industrial contamination may exhibit higher PFAS blood levels compared to those in less affected regions. Additionally, the ongoing emergence of new PFAS compounds poses challenges in tracking and assessing overall exposure globally (NIEHS).

The reliability of the sources cited is high, as they are produced by reputable health organizations and government agencies. However, the potential for bias exists in the interpretation of data, particularly if the focus is primarily on U.S. populations without considering international contexts.

Conclusion

The claim that "PFAS are found in the blood of nearly every person on Earth" is Partially True. While it is well-supported that a significant majority of the U.S. population has PFAS in their blood, the assertion does not account for the variability in exposure and detection rates globally. Therefore, while the evidence strongly supports widespread exposure, it does not conclusively establish that PFAS are present in the blood of nearly every individual worldwide.

Sources

  1. Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS)
  2. Fast Facts: PFAS in the U.S. Population | PFAS and Your Health | ATSDR
  3. Per- and poly-fluoroalkyl substances (PFAS) in circulation in a ...
  4. Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS)
  5. Per- and Polyfluoroalkyl Substances (PFAS) - National Institute of ...
  6. 'Forever Chemicals' Are Everywhere. Most of Their Health Effects Are ...
  7. New study of PFAS forever chemicals highlights need to ...
  8. It's Time to Say Goodbye to "Forever Chemicals"

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check: PFAS levels in the human blood are rising
False
🎯 Similar

Fact Check: PFAS levels in the human blood are rising

Detailed fact-check analysis of: PFAS levels in the human blood are rising

Jun 16, 2025
Read more →
Fact Check:  PFAS manufacturers 3M and DuPont agreed to pay at least $12.5 billion 💰for their roles in contaminating state landfills and rivers with “forever chemicals.” For over 50 years, they knew that PFAS exposure could be linked to kidney and testicular cancer, but chose to keep the risk hidden from the public.

Those affected may be eligible for compensation. Check eligibility for a settlement today with our 1-minute evaluation. ⚡️
Partially True
🎯 Similar

Fact Check: PFAS manufacturers 3M and DuPont agreed to pay at least $12.5 billion 💰for their roles in contaminating state landfills and rivers with “forever chemicals.” For over 50 years, they knew that PFAS exposure could be linked to kidney and testicular cancer, but chose to keep the risk hidden from the public. Those affected may be eligible for compensation. Check eligibility for a settlement today with our 1-minute evaluation. ⚡️

Detailed fact-check analysis of: PFAS manufacturers 3M and DuPont agreed to pay at least $12.5 billion 💰for their roles in contaminating state landfills and rivers with “forever chemicals.” For over 50 years, they knew that PFAS exposure could be linked to kidney and testicular cancer, but chose to keep the risk hidden from the public. Those affected may be eligible for compensation. Check eligibility for a settlement today with our 1-minute evaluation. ⚡️

Jul 30, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: Over 23,000 sites in Europe are contaminated with PFAS.
Partially True

Fact Check: Over 23,000 sites in Europe are contaminated with PFAS.

Detailed fact-check analysis of: Over 23,000 sites in Europe are contaminated with PFAS.

Jul 2, 2025
Read more →
Fact Check: More than 23,000 sites in Europe are contaminated with Pfas.
Partially True

Fact Check: More than 23,000 sites in Europe are contaminated with Pfas.

Detailed fact-check analysis of: More than 23,000 sites in Europe are contaminated with Pfas.

Jul 1, 2025
Read more →